Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

POTASSIUM CITRATE ER 5 MEQ TAB

potassium citrate
$0.1229per EA

Strength

5 meq/1

Manufacturer

Upsher-Smith Laboratories LLC

NDC

00245007011

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

New Drug (NDA)

FDA Application

NDA019071

On Market Since

9/1/2006

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price History

1W

0.0%

1M

+1.0%

3M

-4.1%

6M

-1.8%

1Y

-24.9%

3Y

-25.8%

5Y

-74.6%

All

-81.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

EPSOM SALT GRANULES
Generic
46122046119•AmerisourceBergen
$0.0024
per GM
EPSOM SALT
Generic
70000002102•Cardinal Health
$0.0024
per GM
EPSOM SALT GRANULES
Generic
46122046143•AmerisourceBergen
$0.0039
per GM
EPSOM SALT
Generic
70000002101•Cardinal Health
$0.0039
per GM
FT EPSOM SALT GRANULES
Generic
70677121001•Strategic Sourcing Services LLC
$0.0039
per GM
QC EPSOM SALT GRANULES
Generic
83324017516•Chain Drug Marketing Association
$0.0039
per GM
HM EPSOM SALT
Generic
62011036201•Strategic Sourcing Services LLC
$0.0040
per GM
LACTATED RINGERS INJECTION
Generic
00264775000•B. Braun Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00264775007•B. Braun Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00264775010•B. Braun Medical Inc.
$0.0040
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy